Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review

BACKGROUND AND OBJECTIVES: Short-term studies focused on once-monthly paliperidone palmitate (PP) at doses of 25 mg eq, 50 mg eq, 75 mg eq, 100 mg eq, or 150 mg eq have shown its efficacy and tolerability in the treatment of schizophrenia patients. However, few open-label and long-term studies are a...

全面介紹

Na minha lista:
書目詳細資料
發表在:Patient Prefer Adherence
Main Authors: González-Rodríguez, Alexandre, Catalán, Rosa, Penadés, Rafael, Garcia-Rizo, Clemente, Bioque, Miquel, Parellada, Eduard, Bernardo, Miquel
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2015
主題:
Review
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4459629/
https://ncbi.nlm.nih.gov/pubmed/26082620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S63948
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍